Article

  • The EMBO Journal (2003) 22, 3580 - 3590
  • doi:10.1093/emboj/cdg343

Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway

Bernhard Gillissen1, Frank Essmann1,2, Vilma Graupner1, Lilian Stärck1, Silke Radetzki1, Bernd Dörken1, Klaus Schulze-Osthoff2 and Peter T. Daniel1

  1. Department of Hematology, Oncology and Tumor Immunology, Charité–Campus Berlin-Buch, Humboldt University, D-13125 Berlin-Buch, Germany
  2. Institute of Molecular Medicine, University of Düsseldorf, Düsseldorf, Germany

Correspondence to:

Peter T. Daniel, E-mail: pdaniel@mdc-berlin.de

Received 17 July 2002; Accepted 19 May 2003; Revised 24 April 2003


Nbk/Bik (natural born killer/Bcl-2-interacting killer) is a tissue-specific BH3-only protein whose molecular function is still largely unknown. To investigate the mechanism of Nbk action, we established a single- vector adenoviral system based on the Tet-off conditional expression of Nbk. Upon Nbk expression, only Bax-positive, but not Bax-deficient cells were found to undergo apoptosis. Interestingly, Nbk failed to induce apoptosis in the absence of Bax, even despite expression of the related molecule Bak. Re-expression of Bax restored the sensitivity to Nbk. Similarly, Bax wild-type HCT116 cells were highly susceptible, whereas HCT116 Bax knock-out cells remained resistant to Nbk-induced apoptosis. In Bax-positive cells, Nbk induced a conformational switch in the Bax N-terminus coinciding with cytochrome c release, mitochondrial permeability transition and caspase-9 processing. Immunoprecipitation studies revealed that Nbk interacts with Bcl-xL and Bcl-2 but not with Bax. Since, in addition, Nbk did not localize to the mitochondria, our data suggest a model in which Nbk acts as an indirect killer to trigger Bax-dependent apoptosis, whereas Bak is not sufficient to confer sensitivity to Nbk.

  • Keywords:

    • apoptosis,
    • Bax,
    • Bik,
    • mitochondria,
    • Nbk